UiPath (NASDAQ:PATH) PT Raised to $86.00 at KeyCorp

UiPath (NASDAQ:PATH) had its price target increased by KeyCorp from $82.00 to $86.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the healthcare company’s stock. KeyCorp’s price target would suggest a potential upside of 16.17% from the company’s previous close.

A number of other analysts have also weighed in on the stock. Wells Fargo & Company assumed coverage on shares of UiPath in a research report on Monday, May 17th. They issued an “equal weight” rating and a $75.00 price objective on the stock. BMO Capital Markets assumed coverage on shares of UiPath in a research report on Monday, May 17th. They set a “market perform” rating and a $80.00 target price on the stock. Truist assumed coverage on shares of UiPath in a research report on Monday, May 17th. They set a “buy” rating and a $80.00 target price on the stock. They noted that the move was a valuation call. Royal Bank of Canada assumed coverage on shares of UiPath in a research report on Monday, May 17th. They set a “sector perform” rating and a $74.00 target price on the stock. Finally, Macquarie assumed coverage on shares of UiPath in a research report on Monday, May 17th. They set a “neutral” rating and a $69.00 target price on the stock. Eleven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. UiPath presently has a consensus rating of “Hold” and a consensus price target of $76.89.

Shares of NASDAQ:PATH opened at $74.03 on Wednesday. UiPath has a 12 month low of $61.50 and a 12 month high of $90.00. The firm has a 50-day simple moving average of $56.76.

UiPath (NASDAQ:PATH) last posted its quarterly earnings data on Monday, June 7th. The healthcare company reported $0.02 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.05) by $0.07.

In other UiPath news, CEO Daniel Dines sold 1,383,168 shares of the firm’s stock in a transaction that occurred on Friday, April 23rd. The shares were sold at an average price of $56.00, for a total value of $77,457,408.00. Also, Director Laela Sturdy sold 1,527,673 shares of the firm’s stock in a transaction that occurred on Friday, April 23rd. The shares were sold at an average price of $56.00, for a total transaction of $85,549,688.00. Over the last 90 days, insiders sold 5,011,241 shares of company stock valued at $280,629,496.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows.

Featured Article: Fibonacci Channel

Analyst Recommendations for UiPath (NASDAQ:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.